These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 32124440
21. An unusual clinical and pathological presentation of a nodular lymphocyte predominant Hodgkin lymphoma ("Poppema Lennert" lymphoma). Ben Rejeb S, Dhaoui A, Ben Ghachem D, Jomni T, Abouda M, Abouda M, Turki S, Bellil K. Tunis Med; 2016 Feb; 94(2):159-61. PubMed ID: 27532537 [No Abstract] [Full Text] [Related]
24. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma. McKay P, Fielding P, Gallop-Evans E, Hall GW, Lambert J, Leach M, Marafioti T, McNamara C, British Committee for Standards in Haematology. Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004 [No Abstract] [Full Text] [Related]
25. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma. Cho BB, Kelting SM, Gru AA, LeGallo RD, Pramoonjago P, Goldin TA, Heitz CT, Aguilera NS. Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705 [Abstract] [Full Text] [Related]
26. [Differential diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma and lymphocyte-rich classic Hodgkin lymphoma: role of immunohistochemistry]. He YM, Li GD, Li FY, Jiang W, Ji H, Liao DY, Liu WP, Li YC, Li WF, Chen Y, Yang YH, Wang SX, Yang ZR. Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):416-7. PubMed ID: 17822631 [No Abstract] [Full Text] [Related]
27. Clinically unsuspected Hodgkin disease presenting initially in the bone marrow of patients infected with the human immunodeficiency virus. Karcher DS. Cancer; 1993 Feb 15; 71(4):1235-8. PubMed ID: 8435799 [Abstract] [Full Text] [Related]
28. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Churchill HR, Roncador G, Warnke RA, Natkunam Y. Hum Pathol; 2010 Dec 15; 41(12):1726-34. PubMed ID: 20825974 [Abstract] [Full Text] [Related]
29. Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma. Yigit N, Wu WW, Covey S, Tam W. Int J Hematol; 2015 Mar 15; 101(3):211-2. PubMed ID: 25552246 [No Abstract] [Full Text] [Related]
30. Clinicopathological Features of Bone Marrow Infiltration in Hodgkin Lymphoma. Should Bone Marrow Staging Be Done Only in High Risk Patients? Sudalaimuthu M, Basu D. Turk Patoloji Derg; 2017 Mar 15; 33(2):129-133. PubMed ID: 28272679 [Abstract] [Full Text] [Related]
31. Variant histology nodular lymphocyte predominant Hodgkin lymphoma - a route to transformation? Szychot E, Shankar A, Haider A, Ramsay A. Br J Haematol; 2018 May 15; 181(3):403-406. PubMed ID: 28369705 [No Abstract] [Full Text] [Related]
32. Bone marrow involvement by hodgkin and non-hodgkin lymphomas. Zhang QY, Foucar K. Hematol Oncol Clin North Am; 2009 Aug 15; 23(4):873-902. PubMed ID: 19577173 [Abstract] [Full Text] [Related]
33. Prevalence and aetiology of anaemia in lymphoid malignancies. Ghosh J, Singh RK, Saxena R, Gupta R, Vivekanandan S, Sreenivas V, Raina V, Sharma A, Kumar L. Natl Med J India; 2013 Aug 15; 26(2):79-81. PubMed ID: 24093980 [Abstract] [Full Text] [Related]
34. Bone marrow biopsy (BMB). III. Bone marrow biopsy in Hodgkin's disease (HD). Macavei I, Galatâr N. Morphol Embryol (Bucur); 1990 Aug 15; 36(1):25-32. PubMed ID: 2149408 [Abstract] [Full Text] [Related]
35. Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy. Garciaz S, Harel S, Amorim S, Bouabdallah R, Thieblemont C, Brice P. Br J Haematol; 2016 Nov 15; 175(4):735-737. PubMed ID: 26685097 [No Abstract] [Full Text] [Related]
36. Reed-Sternberg cells detected in the bone marrow aspirate in a young patient with nodular sclerosis Hodgkin lymphoma. Xu Z, Burns BF, Faught C. Eur J Haematol; 2014 Apr 15; 92(4):365-6. PubMed ID: 23902293 [No Abstract] [Full Text] [Related]
37. Long-term follow-up of 2 patients treated with 90 Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma. Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D. Eur J Haematol; 2018 Sep 15; 101(3):415-417. PubMed ID: 29719928 [Abstract] [Full Text] [Related]
38. Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia. Li G, Hansmann ML. Virchows Arch A Pathol Anat Histopathol; 1989 Sep 15; 415(5):481-7. PubMed ID: 2508307 [Abstract] [Full Text] [Related]
39. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant. Drakos E, Rassidakis GZ, Leventaki V, Cotta CV, Vega F, Medeiros LJ. Am J Surg Pathol; 2009 Nov 15; 33(11):1725-31. PubMed ID: 19730363 [Abstract] [Full Text] [Related]
40. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma. Uherova P, Olson S, Thompson MA, Juskevicius R, Hamilton KS. Appl Immunohistochem Mol Morphol; 2004 Jun 15; 12(2):105-10. PubMed ID: 15354734 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]